Hexagon Bio

Hexagon Bio
Developing novel therapeutics by understanding the complex interplay of biological systems.
About
Technology stack
detected 2026-07-14No comments yet. Be the first to share your take.
What does Hexagon Bio do?
Hexagon Bio is a biotechnology company focused on developing new medicines by leveraging a deep understanding of biological pathways and interactions. They aim to create therapies for diseases with high unmet medical needs.
How much funding has Hexagon Bio raised?
Hexagon Bio has raised a total of $100M in funding. The most recent round on record is Series B.
Where is Hexagon Bio headquartered?
Hexagon Bio is headquartered in Menlo Park, United States.
When was Hexagon Bio founded?
Hexagon Bio was founded in 2019.
What industry does Hexagon Bio operate in?
Hexagon Bio operates in Biotech, Drug Discovery, Genomics, HealthTech, Therapeutics.
How many employees does Hexagon Bio have?
Hexagon Bio has approximately 70 people on record.
What is Hexagon Bio's revenue?
StartupHub estimates Hexagon Bio's annual revenue at $7.7M (range $4.1M to $31.0M, 64% confidence), based on comparable companies in the sector.
What is Hexagon Bio's valuation?
StartupHub estimates Hexagon Bio's effective valuation at $424.0M (range $250.0M to $600.0M, 10% confidence), based on comparable companies in the sector.